KI
CMD

Kalmar Investments’s Cantel Medical Corporation CMD Stock Holding History

Kalmar Investments’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$3.15M Sell
39,322
-144,805
-79% -$11.5M 0.71% 65
2016
Q4 		$14.5M Sell
184,127
-23,100
-11% -$1.79M 0.75% 70
2016
Q3 		$16.2M Sell
207,227
-78,005
-27% -$5.66M 0.74% 66
2016
Q2 		$19.6M Buy
285,232
+115,832
+68% +$7.99M 0.87% 45
2016
Q1 		$12.1M Buy
+169,400
New +$10.6M 0.5% 77

Other funds holding CMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Diker Management New York $130M AUM 97.77% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kalmar Investments's CMD Position: Q1 2017 in Review

Kalmar Investments reduced its Cantel Medical Corporation (CMD) stake by 79% in Q1 2017, selling an estimated $11.5M and leaving 39,322 shares worth $3.15M. The position accounts for 0.71% of the portfolio, ranked #65.

Kalmar Investments first reported a position in CMD in Q1 2016 and has held it in 5 quarters since. The position peaked at $19.6M in Q2 2016. 218 funds tracked by Wall St. Rank hold CMD as of Q1 2017.

  • Kalmar Investments held 39,322 shares of Cantel Medical Corporation worth $3.15M as of Q1 2017.
  • Kalmar Investments sold 144,805 Cantel Medical Corporation shares in Q1 2017, an estimated $11.5M.
  • Cantel Medical Corporation made up 0.71% of Kalmar Investments's portfolio in Q1 2017, its #65 holding.
  • Kalmar Investments first reported a position in Cantel Medical Corporation in Q1 2016 and has held it in 5 quarters since.
  • Kalmar Investments's Cantel Medical Corporation position peaked at $19.6M in Q2 2016.
  • 218 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2017.

Based on Kalmar Investments's 13F filing for Q1 2017, filed 26 Apr 2017.